MedKoo Cat#: 471001 | Name: MDK6620
Featured New

Description:

WARNING: This product is for research use only, not for human or veterinary use.

MDK6620, also known as BTYNB IMP1 Inhibitor. is an inhibitor of the oncofetal mRNA-binding protein IMP1 (IC50 = 5 μM for IMP1 binding to c-Myc mRNA).

Chemical Structure

MDK6620
MDK6620
CAS#304456-62-0

Theoretical Analysis

MedKoo Cat#: 471001

Name: MDK6620

CAS#: 304456-62-0

Chemical Formula: C12H9BrN2OS

Exact Mass: 307.9619

Molecular Weight: 309.18

Elemental Analysis: C, 46.62; H, 2.93; Br, 25.84; N, 9.06; O, 5.17; S, 10.37

Price and Availability

Size Price Availability Quantity
100mg USD 850.00 2 Weeks
200mg USD 1,350.00 2 Weeks
500mg USD 2,650.00 2 Weeks
1g USD 3,650.00 2 Weeks
2g USD 5,450.00 2 Weeks
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
BTYNB IMP1 Inhibitor; MDK6620; MDK-6620; MDK 6620.
IUPAC/Chemical Name
2-[[(5-bromo-2-thienyl)methylene]amino]-benzamide
InChi Key
OZEADOPONHLEDS-VIZOYTHASA-N
InChi Code
InChI=1S/C12H9BrN2OS/c13-11-6-5-8(17-11)7-15-10-4-2-1-3-9(10)12(14)16/h1-7H,(H2,14,16)/b15-7+
SMILES Code
O=C(N)C1=CC=CC=C1/N=C/C2=CC=C(Br)S2
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 309.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1. L. Mahapatra, N. Andruska, C. Mao, et al. A novel IMP1 inhibitor, BTYNB, targets c-Myc and inhibits melanoma and ovarian cancer cell proliferation. Transl. Oncol. 10(5), 818-827 (2017).